Scientists from the University of Sharjah have found that a naturally growing aromatic plant contains ingredients with the ...

In an era dominated by pricey, high-tech drugs, the humble aspirin had a practice-changing impact on colorectal cancer (CRC) ...

Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefited from first-line treatment with the ...

The risk for colorectal cancer was associated with the frequency of colorectal polyp diagnoses in relatives in a study based ...

Barry Stein had ignored symptoms that started appearing in 1995, until he was diagnosed with stage four colorectal cancer.

Low-dose aspirin significantly reduced risk for colorectal cancer recurrence among patients with mutations in the PI3K pathway, according to results of the randomized ALASCCA study presented at ASCO ...

A new research paper was published in Oncotarget's Volume 16 on January 21, 2025, titled "Assessment of cfDNA release dynamics during colorectal cancer surgery." ...

The CDC advises 45- to 75 year olds to get screened for colorectal cancer regularly. However, the American Cancer Society's statistics show that it is on the rise among people under the age of 50, ...

Anyone can get colorectal cancer. Doctors often don't know why it happens, but they know some of the things that make people more likely to get it. These include: Age. The disease is most common ...

Bristol Myers Squibb’s Opdivo plus Yervoy, as well as Pfizer’s Braftovi, have each shown strong Phase III performances that ...

Old drugs from Bristol Myers Squibb and Pfizer have delivered what the companies and researchers believe could establish them ...

Aspirin did not provide any clinical benefits in a cohort of patients with colorectal cancer who had no history of cardiovascular disease or stroke.